GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (BOM:506197) » Definitions » Purchase Of Investment

Bliss GVS Pharma (BOM:506197) Purchase Of Investment : ₹0 Mil (TTM As of Sep. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Bliss GVS Pharma Purchase Of Investment?

Bliss GVS Pharma's purchase of investment for the three months ended in Sep. 2024 was ₹0 Mil. It means Bliss GVS Pharma spent ₹0 Mil on purchasing investments. Bliss GVS Pharma's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Jun. 2024 ), Bliss GVS Pharma spent the same money on purchasing investments in Sep. 2024 (₹0 Mil).

Bliss GVS Pharma Purchase Of Investment Historical Data

The historical data trend for Bliss GVS Pharma's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Purchase Of Investment Chart

Bliss GVS Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -259.26 -77.07 -1,152.10

Bliss GVS Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bliss GVS Pharma Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bliss GVS Pharma Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Bliss GVS Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (BOM:506197) » Definitions » Purchase Of Investment
Comparable Companies
NSE:BETA BOM:543998 BOM:524470 BOM:531146 BOM:531633 BOM:507789 BOM:543329 BOM:540737 BOM:541540 BOM:506260 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
BLISSGVS:India
Address
Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Website
https://www.blissgvs.com
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from exports.

Bliss GVS Pharma Headlines

No Headlines